International Union of Pharmacology. LII. Nomenclature and Molecular Relationships of Calcium-Activated Potassium Channels
暂无分享,去创建一个
R. Aldrich | K. Chandy | G. Gutman | S. Grissmer | M. Lazdunski | D. Mckinnon | L. Pardo | M. Sanguinetti | W. Stühmer | A. Wei | H. Wulff | Gail A. Robertson | B. Rudy | Xiaoliang Wang
[1] R. Aldrich,et al. Erectile dysfunction in mice lacking the large‐conductance calcium‐activated potassium (BK) channel , 2005, The Journal of physiology.
[2] Tao Xu,et al. BmP09, a “Long Chain” Scorpion Peptide Blocker of BK Channels* , 2005, Journal of Biological Chemistry.
[3] I. Grgic,et al. Selective Blockade of the Intermediate-Conductance Ca2+-Activated K+ Channel Suppresses Proliferation of Microvascular and Macrovascular Endothelial Cells and Angiogenesis In Vivo , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[4] A. Nomeir,et al. Blocking ion channel KCNN4 alleviates the symptoms of experimental autoimmune encephalomyelitis in mice , 2005, European journal of immunology.
[5] IvicaGrgic,et al. Selective Blockade of the Intermediate-Conductance Ca2+-Activated K+ Channel Suppresses Proliferation of Microvascular and Macrovascular Endothelial Cells and Angiogenesis In Vivo , 2005 .
[6] D. H. Cox. The BKCa Channel's Ca2+-binding Sites, Multiple Sites, Multiple Ions , 2005, The Journal of general physiology.
[7] T. Begenisich,et al. Physiological Roles of the Intermediate Conductance, Ca2+-activated Potassium Channel Kcnn4* , 2004, Journal of Biological Chemistry.
[8] P. Christophersen,et al. Activation of human IK and SK Ca2+ -activated K+ channels by NS309 (6,7-dichloro-1H-indole-2,3-dione 3-oxime). , 2004, Biochimica et biophysica acta.
[9] J. Schuhmacher,et al. Selective intermediate‐/small‐conductance calcium‐activated potassium channel (KCNN4) blockers are potent and effective therapeutics in experimental brain oedema and traumatic brain injury caused by acute subdural haematoma , 2004, The European journal of neuroscience.
[10] M. Stocker. Ca2+-activated K+ channels: molecular determinants and function of the SK family , 2004, Nature Reviews Neuroscience.
[11] M. Mann,et al. Protein Kinase CK2 Is Coassembled with Small Conductance Ca2+-Activated K+ Channels and Regulates Channel Gating , 2004, Neuron.
[12] R. Aldrich,et al. Overactive Bladder and Incontinence in the Absence of the BK Large Conductance Ca2+-activated K+ Channel* , 2004, Journal of Biological Chemistry.
[13] J F Storm,et al. Cerebellar ataxia and Purkinje cell dysfunction caused by Ca2+-activated K+ channel deficiency. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[14] C. Lingle,et al. Ligand-Dependent Activation of Slo Family Channels Is Defined by Interchangeable Cytosolic Domains , 2004, The Journal of Neuroscience.
[15] R. Stackman,et al. Small Conductance Ca2+-Activated K+ Channel Knock-Out Mice Reveal the Identity of Calcium-Dependent Afterhyperpolarization Currents , 2004, The Journal of Neuroscience.
[16] S. Marx,et al. Assembly of a Ca2+‐dependent BK channel signaling complex by binding to β2 adrenergic receptor , 2004, The EMBO journal.
[17] Michael Pennington,et al. K+ channels as targets for specific immunomodulation. , 2004, Trends in pharmacological sciences.
[18] Rodrigo Andrade,et al. SKCa Channels Mediate the Medium But Not the Slow Calcium-Activated Afterhyperpolarization in Cortical Neurons , 2004, The Journal of Neuroscience.
[19] K. Chandy,et al. Enhanced neuronal excitability in the absence of neurodegeneration induces cerebellar ataxia. , 2004, The Journal of clinical investigation.
[20] L. Kaczmarek,et al. Slick (Slo2.1), a Rapidly-Gating Sodium-Activated Potassium Channel Inhibited by ATP , 2003, The Journal of Neuroscience.
[21] Yi Zhang,et al. Molecular Identification and Functional Roles of a Ca2+-activated K+ Channel in Human and Mouse Hearts* , 2003, Journal of Biological Chemistry.
[22] J. Adelman,et al. Urinary bladder instability induced by selective suppression of the murine small conductance calcium-activated potassium (SK3) channel. , 2003, The Journal of physiology.
[23] K. Chandy,et al. Blockade of the Intermediate-Conductance Calcium-Activated Potassium Channel as a New Therapeutic Strategy for Restenosis , 2003, Circulation.
[24] J. Stasch,et al. 4-Phenyl-4H-pyrans as IK(Ca) channel blockers. , 2003, Bioorganic & medicinal chemistry letters.
[25] Mark S Taylor,et al. Altered Expression of Small‐Conductance Ca2+‐Activated K+ (SK3) Channels Modulates Arterial Tone and Blood Pressure , 2003, Circulation research.
[26] P. Sah,et al. Calcium-Activated Potassium Channels: Multiple Contributions to Neuronal Function , 2003, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.
[27] J. Stocker,et al. ICA-17043, a novel Gardos channel blocker, prevents sickled red blood cell dehydration in vitro and in vivo in SAD mice. , 2003, Blood.
[28] L. Kaczmarek,et al. The Sodium-Activated Potassium Channel Is Encoded by a Member of the Slo Gene Family , 2003, Neuron.
[29] A. Pries,et al. Selective blockade of endothelial Ca2+‐activated small‐ and intermediate‐conductance K+‐channels suppresses EDHF‐mediated vasodilation , 2003, British journal of pharmacology.
[30] K. Magleby. Gating Mechanism of BK (Slo1) Channels , 2003, The Journal of general physiology.
[31] L. Kaczmarek,et al. Localization of the Slack potassium channel in the rat central nervous system , 2002, The Journal of comparative neurology.
[32] J. Joseph,et al. Tamapin, a Venom Peptide from the Indian Red Scorpion (Mesobuthus tamulus) That Targets Small Conductance Ca2+-activated K+ Channels and Afterhyperpolarization Currents in Central Neurons* , 2002, The Journal of Biological Chemistry.
[33] D. Trezise,et al. Partial apamin sensitivity of human small conductance Ca2+-activated K+ channels stably expressed in Chinese hamster ovary cells , 2002, Naunyn-Schmiedeberg's Archives of Pharmacology.
[34] C. Lingle. Setting the Stage for Molecular Dissection of the Regulatory Components of BK Channels , 2002, The Journal of general physiology.
[35] J. Qin,et al. Mechanism of magnesium activation of calcium-activated potassium channels , 2002, Nature.
[36] C. Lingle,et al. Multiple regulatory sites in large-conductance calcium-activated potassium channels , 2002, Nature.
[37] P. Vanhoutte,et al. Characterization of an apamin‐sensitive small‐conductance Ca2+‐activated K+ channel in porcine coronary artery endothelium: relevance to EDHF , 2002, British journal of pharmacology.
[38] I. Levitan,et al. Modulation of calcium-activated potassium channels , 2002, Journal of Comparative Physiology A.
[39] K. Chandy,et al. Modulation of Mouse Paneth Cell α-Defensin Secretion by mIKCa1, a Ca2+-activated, Intermediate Conductance Potassium Channel* , 2002, The Journal of Biological Chemistry.
[40] K. Chandy,et al. Design and Characterization of a Highly Selective Peptide Inhibitor of the Small Conductance Calcium-activated K+Channel, SkCa2* , 2001, The Journal of Biological Chemistry.
[41] Jingyi Shi,et al. Intracellular Mg2+ Enhances the Function of Bk-Type Ca2+-Activated K+ Channels , 2001, The Journal of general physiology.
[42] L. Kaczmarek,et al. Calmodulin regulates assembly and trafficking of SK4/IK1 Ca2+-activated K+ channels. , 2001, The Journal of biological chemistry.
[43] D. Geschwind,et al. Association of moderate polyglutamine tract expansions in the slow calcium-activated potassium channel type 3 with ataxia. , 2001, Archives of neurology.
[44] J. Adelman,et al. Small‐conductance calcium‐activated potassium currents in mouse hyperexcitable denervated skeletal muscle , 2001, The Journal of physiology.
[45] D. Jenkinson,et al. SK3 is an important component of K+ channels mediating the afterhyperpolarization in cultured rat SCG neurones , 2001, The Journal of physiology.
[46] S Athmani,et al. Synthesis and structure-activity relationships of cetiedil analogues as blockers of the Ca(2+)-activated K+ permeability of erythrocytes. , 2001, Journal of medicinal chemistry.
[47] J. Gargus,et al. Genomic organization and promoter analysis of human KCNN3 gene , 2001, Journal of Human Genetics.
[48] Mark J. Miller,et al. Nuclear Localization and Dominant-negative Suppression by a Mutant SKCa3 N-terminal Channel Fragment Identified in a Patient with Schizophrenia* , 2001, The Journal of Biological Chemistry.
[49] Kamilla Angelo,et al. Pharmacological modulation of SK3 channels , 2001, Neuropharmacology.
[50] Jochen Roeper,et al. Differential Expression of the Small-Conductance, Calcium-Activated Potassium Channel SK3 Is Critical for Pacemaker Control in Dopaminergic Midbrain Neurons , 2001, The Journal of Neuroscience.
[51] M. Gopalakrishnan,et al. Recent developments in the biology and medicinal chemistry of potassium channel modulators: update from a decade of progress. , 2001, Journal of medicinal chemistry.
[52] L. Jones,et al. Mutation screening of the KCNN3 gene reveals a rare frameshift mutation , 2001, Molecular Psychiatry.
[53] J. Adelman,et al. Structure of the gating domain of a Ca2+-activated K+ channel complexed with Ca2+/calmodulin , 2001, Nature.
[54] A. Moore,et al. Cloning and functional expression of a liver isoform of the small conductance Ca2+-activated K+ channel SK3. , 2001, American journal of physiology. Cell physiology.
[55] Astrid A. Ortiz,et al. Targeting acute ischemic stroke with a calcium-sensitive opener of maxi-K potassium channels , 2001, Nature Medicine.
[56] B. Fakler,et al. Control of Electrical Activity in Central Neurons by Modulating the Gating of Small Conductance Ca2+-activated K+ Channels* , 2001, The Journal of Biological Chemistry.
[57] M. T. Roberts,et al. Modulation of recombinant small-conductance Ca(2+)-activated K(+) channels by the muscle relaxant chlorzoxazone and structurally related compounds. , 2001, The Journal of pharmacology and experimental therapeutics.
[58] A. K. Singh,et al. Benzimidazolone activators of chloride secretion: potential therapeutics for cystic fibrosis and chronic obstructive pulmonary disease. , 2001, The Journal of pharmacology and experimental therapeutics.
[59] S. Sakoda,et al. The expression of ion channel mRNAs in skeletal muscles from patients with myotonic muscular dystrophy , 2000, Neuroscience Letters.
[60] Mark J. Miller,et al. Up-regulation of the IKCa1 Potassium Channel during T-cell Activation , 2000, The Journal of Biological Chemistry.
[61] R. Köhler,et al. Expression and Function of Endothelial Ca2+-Activated K+ Channels in Human Mesenteric Artery: A Single-Cell Reverse Transcriptase–Polymerase Chain Reaction and Electrophysiological Study In Situ , 2000, Circulation research.
[62] D. Strøbæk,et al. Activation of the human, intermediate-conductance, Ca2+-activated K+ channel by methylxanthines , 2000, Pflügers Archiv.
[63] L. Salkoff,et al. SLO-2, a K+ channel with an unusual Cl− dependence , 2000, Nature Neuroscience.
[64] M. T. Roberts,et al. Block of rat brain recombinant SK channels by tricyclic antidepressants and related compounds. , 2000, European journal of pharmacology.
[65] K. Chandy,et al. Design of a potent and selective inhibitor of the intermediate-conductance Ca2+-activated K+ channel, IKCa1: a potential immunosuppressant. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[66] P. Distefano,et al. A Novel Nervous System β Subunit that Downregulates Human Large Conductance Calcium-Dependent Potassium Channels , 2000, The Journal of Neuroscience.
[67] S. F. Konieczny,et al. Ras/MEK/ERK Up-regulation of the Fibroblast KCaChannel FIK Is a Common Mechanism for Basic Fibroblast Growth Factor and Transforming Growth Factor-β Suppression of Myogenesis* , 2000, The Journal of Biological Chemistry.
[68] P. Pedarzani,et al. Differential Distribution of Three Ca2+-Activated K+ Channel Subunits, SK1, SK2, and SK3, in the Adult Rat Central Nervous System , 2000, Molecular and Cellular Neuroscience.
[69] S. Grissmer,et al. SK2 encodes the apamin‐sensitive Ca2+‐activated K+ channels in the human leukemic T cell line, Jurkat , 2000, FEBS letters.
[70] D. Strøbæk,et al. Pharmacological characterization of small‐conductance Ca2+‐activated K+ channels stably expressed in HEK 293 cells , 2000, British journal of pharmacology.
[71] M. Shah,et al. The pharmacology of hSK1 Ca2+‐activated K+ channels expressed in mammalian cell lines , 2000, British journal of pharmacology.
[72] K. Chandy,et al. Structure-guided Transformation of Charybdotoxin Yields an Analog That Selectively Targets Ca2+-activated over Voltage-gated K+ Channels* , 2000, The Journal of Biological Chemistry.
[73] D. Valle,et al. Online Mendelian Inheritance In Man (OMIM) , 2000, Human mutation.
[74] S. Heinemann,et al. Identification of Ether à Go-Go and Calcium-Activated Potassium Channels in Human Melanoma Cells , 1999, The Journal of Membrane Biology.
[75] D. Strøbæk,et al. Activation of the human intermediate-conductance Ca(2+)-activated K(+) channel by 1-ethyl-2-benzimidazolinone is strongly Ca(2+)-dependent. , 1999, Biochimica et biophysica acta.
[76] A. Bruening-Wright,et al. Bicuculline block of small-conductance calcium-activated potassium channels , 1999, Pflügers Archiv.
[77] C. Lingle,et al. Molecular Basis for the Inactivation of Ca2+- and Voltage-Dependent BK Channels in Adrenal Chromaffin Cells and Rat Insulinoma Tumor Cells , 1999, The Journal of Neuroscience.
[78] N. Craddock,et al. CAG repeat length in the hKCa3 gene and symptom dimensions in schizophrenia , 1999, Biological Psychiatry.
[79] A. Janowsky,et al. Skeletal muscle and small‐conductance calcium‐activated potassium channels , 1999, Muscle & nerve.
[80] L. Kaczmarek,et al. hSK4/hIK1, a Calmodulin-binding KCa Channel in Human T Lymphocytes , 1999, The Journal of Biological Chemistry.
[81] L. Salkoff,et al. Transplantable sites confer calcium sensitivity to BK channels , 1999, Nature Neuroscience.
[82] R. Weizman,et al. hKCa3/KCNN3 potassium channel gene: association of longer CAG repeats with schizophrenia in Israeli Ashkenazi Jews, expression in human tissues and localization to chromosome 1q21 , 1999, Molecular Psychiatry.
[83] J. Adelman,et al. Small‐Conductance Calcium‐Activated Potassium Channels , 1999, Annals of the New York Academy of Sciences.
[84] K. Chandy,et al. Calmodulin Mediates Calcium-dependent Activation of the Intermediate Conductance KCa Channel,IKCa1 * , 1999, The Journal of Biological Chemistry.
[85] L. Kaczmarek,et al. Formation of intermediate-conductance calcium-activated potassium channels by interaction of Slack and Slo subunits , 1998, Nature Neuroscience.
[86] T. Ishii,et al. Mechanism of calcium gating in small-conductance calcium-activated potassium channels , 1998, Nature.
[87] K. Chandy,et al. Human calcium-activated potassium channel gene KCNN4 maps to chromosome 19q13.2 in the region deleted in diamond-blackfan anemia. , 1998, Genomics.
[88] Neil V Marrion,et al. Calcium-activated potassium channels , 1998, Current Opinion in Neurobiology.
[89] Jiuyong Xie,et al. Control of alternative splicing of potassium channels by stress hormones. , 1998, Science.
[90] N. Marrion,et al. Gating of Recombinant Small-Conductance Ca-activated K+ Channels by Calcium , 1998, The Journal of general physiology.
[91] L. Salkoff,et al. Slo3, a Novel pH-sensitive K+ Channel from Mammalian Spermatocytes* , 1998, The Journal of Biological Chemistry.
[92] E. Christian,et al. A Novel Gene, hKCa4, Encodes the Calcium-activated Potassium Channel in Human T Lymphocytes* , 1997, The Journal of Biological Chemistry.
[93] S. Alper,et al. The antifungal antibiotic, clotrimazole, inhibits chloride secretion by human intestinal T84 cells via blockade of distinct basolateral K+ conductances. Demonstration of efficacy in intact rabbit colon and in an in vivo mouse model of cholera. , 1997, The Journal of clinical investigation.
[94] L. Toro,et al. Large conductance voltage- and calcium-dependent K+ channel, a distinct member of voltage-dependent ion channels with seven N-terminal transmembrane segments (S0-S6), an extracellular N terminus, and an intracellular (S9-S10) C terminus. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[95] T. Ishii,et al. A human intermediate conductance calcium-activated potassium channel. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[96] L. Kaczmarek,et al. hSK4, a member of a novel subfamily of calcium-activated potassium channels. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[97] T. Ishii,et al. Determinants of Apamin and d-Tubocurarine Block in SK Potassium Channels* , 1997, The Journal of Biological Chemistry.
[98] L. Salkoff,et al. A novel calcium-sensing domain in the BK channel. , 1997, Biophysical journal.
[99] O. McManus,et al. Paxilline Inhibition of the Alpha-subunit of the High-conductance Calcium-activated Potassium Channel , 1996, Neuropharmacology.
[100] D. Strøbæk,et al. Modulation of the Ca2+-dependent K+ Channel, hslo, by the Substituted Diphenylurea NS 1608, Paxilline and Internal Ca2+ , 1996, Neuropharmacology.
[101] N. Marrion,et al. Small-Conductance, Calcium-Activated Potassium Channels from Mammalian Brain , 1996, Science.
[102] O. McManus,et al. High-conductance calcium-activated potassium channels; Structure, pharmacology, and function , 1996, Journal of bioenergetics and biomembranes.
[103] O. Platt,et al. Therapy with oral clotrimazole induces inhibition of the Gardos channel and reduction of erythrocyte dehydration in patients with sickle cell disease. , 1996, The Journal of clinical investigation.
[104] J. Tseng-Crank,et al. Cloning, expression, and distribution of functionally distinct Ca2+-activated K+ channel isoforms from human brain , 1994, Neuron.
[105] L. Salkoff,et al. Calcium sensitivity of BK-type KCa channels determined by a separable domain , 1994, Neuron.
[106] R. North,et al. Functional differences among alternatively spliced variants of Slowpoke, a Drosophila calcium-activated potassium channel. , 1994, The Journal of biological chemistry.
[107] L. Pallanck,et al. Cloning and characterization of human and mouse homologs of the Drosophila calcium-activated potassium channel gene, slowpoke. , 1994, Human molecular genetics.
[108] M. Garcia-Calvo,et al. Subunit composition of the high conductance calcium-activated potassium channel from smooth muscle, a representative of the mSlo and slowpoke family of potassium channels. , 1994, The Journal of biological chemistry.
[109] O. McManus,et al. Purification and reconstitution of the high-conductance, calcium-activated potassium channel from tracheal smooth muscle. , 1994, The Journal of biological chemistry.
[110] S. Grissmer,et al. Calcium-activated potassium channels in resting and activated human T lymphocytes. Expression levels, calcium dependence, ion selectivity, and pharmacology , 1993, The Journal of general physiology.
[111] L. Salkoff,et al. mSlo, a complex mouse gene encoding "maxi" calcium-activated potassium channels. , 1993, Science.
[112] O. McManus,et al. An activator of calcium-dependent potassium channels isolated from a medicinal herb. , 1993, Biochemistry.
[113] N. Atkinson,et al. A component of calcium-activated potassium channels encoded by the Drosophila slo locus. , 1991, Science.
[114] H. Irisawa,et al. Intracellular Na+ activates a K+ channel in mammalian cardiac cells , 1984, Nature.
[115] G. Gardos,et al. The function of calcium in the potassium permeability of human erythrocytes. , 1958, Biochimica et biophysica acta.
[116] L. Rüttiger,et al. Deletion of the Ca2+-activated potassium (BK) alpha-subunit but not the BKbeta1-subunit leads to progressive hearing loss. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[117] Abraham Weizman,et al. Association between anorexia nervosa and the hsKCa3 gene: a family-based and case control study , 2002, Molecular Psychiatry.
[118] D. H. Cox,et al. Elimination of the BK Ca Channel’s High-Affinity Ca 2 (cid:2) Sensitivity , 2002 .
[119] L. Possani,et al. Slotoxin, alphaKTx1.11, a new scorpion peptide blocker of MaxiK channels that differentiates between alpha and alpha+beta (beta1 or beta4) complexes. , 2001, FEBS letters.
[120] Jingyi Shi,et al. Intracellular Mg 2 Enhances the Function of BK-type Ca 2-activated K Channels , 2001 .
[121] Mark J. Miller,et al. Selective blockers and manipulated channel expression levels , 2001 .
[122] K. Chandy,et al. Design and Characterization of a Highly Selective Peptide Inhibitor of the Small Conductance Calcium-activated K Channel , SkCa 2 * , 2001 .
[123] K. Magleby,et al. Gating and conductance properties of BK channels are modulated by the S9-S10 tail domain of the alpha subunit. A study of mSlo1 and mSlo3 wild-type and chimeric channels. , 2001, The Journal of general physiology.
[124] L. Toro,et al. Human and rodent MaxiK channel beta-subunit genes: cloning and characterization. , 1999, Genomics.
[125] R. Latorre,et al. Acute activation of Maxi-K channels (hSlo) by estradiol binding to the beta subunit. , 1999, Science.
[126] P. Christophersen,et al. Inhibition of T cell proliferation by selective block of Ca(2+)-activated K(+) channels. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[127] G A Gutman,et al. Isolation of a novel potassium channel gene hSKCa3 containing a polymorphic CAG repeat: a candidate for schizophrenia and bipolar disorder? , 1998, Molecular Psychiatry.
[128] J. Ding,et al. Calcium-activated potassium channels in adrenal chromaffin cells. , 1996, Ion channels.
[129] M. Lazdunski,et al. Apamin: a specific toxin to study a class of Ca2+-dependent K+ channels. , 1984, Journal de physiologie.